Las Vegas, NV -- (SBWIRE) -- 10/04/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP), Zogenix, Inc. (NASDAQ:ZGNX), Arca Biopharma Inc (NASDAQ:ABIO), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN).
Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP) managed to keep its gain at 2.56% on traded volume of 3.82 million shares. The stock settled at $1.60 after floating in a range of $1.54 to $1.65. After recent close, it has reached market capitalization of $289.34 million. Its 52-week range has been $0.30 to $1.99. Suntech Power Holdings Co., Ltd. (Suntech) is a solar energy company. Suntech is principally engaged in the design, development, manufacturing and marketing of photovoltaic (PV) products
Will STP Continue To Move Higher? Find Out Here
Zogenix, Inc. (NASDAQ:ZGNX) traded up on a volume of 3.78 million, higher than its standard daily volume. Shares have gained 11.61% to $2.50. Over the last twelve months the stock has lost -5.3% and faced a worst price of $2.25. Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain.
Will ZGNX Continue To Move Higher? Find Out Here
Arca Biopharma Inc (NASDAQ:ABIO) settled -2.97% lower at $1.60 on traded volume of 3.53 million shares during the last trading day, while its average trading volume remained 649.433 shares. The stock has its 12-month low at $1.13 and 52-week high price was $5.93. It traded in a range of $1.52 to $1.79 during the last trading day. ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company's principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases.
Will ABIO Get Buyers Even After The Recent Rally? Find Out Here
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) saw its price fall on traded volume as 3.46 million shares changed hands when compared with its average daily volume of 3.13 million shares. The stock was down -3.47% to $2.78. It has fallen over the last 12 months, dropping -73.28% and marked new low $2.62. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases.
Will ACHN Get Buyers Even After The Recent Rally? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)